β1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction.

Lymperopoulos, Anastasios

β1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction. [electronic resource] - Pharmacogenomics Oct 2013 - 1545-9 p. digital

Publication Type: Journal Article

1744-8042

10.2217/pgs.13.137 doi


Adrenergic alpha-1 Receptor Antagonists--therapeutic use
Anti-Arrhythmia Agents--therapeutic use
Heart Failure--drug therapy
Humans
Polymorphism, Genetic--genetics
Propanolamines--therapeutic use
Receptors, Adrenergic, alpha-2--genetics
Receptors, Adrenergic, beta-1--genetics